PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Rapid IV Opioid Titration Delivers Fast Relief in Palliative Crises

morphineoxycodoneopioidsintravenous titrationcancer paindyspneapalliative careretrospective cohortsymptom crisispatient satisfaction Palliative Care

Background Information

Rapid opioid titration swiftly eases acute crises in palliative care with minimal side effects.

Managing acute symptom crises such as pain and dyspnea in palliative care is critical, and understanding the effectiveness of rapid intravenous opioid titration is essential for improving patient comfort. Rapid intravenous opioid titration in 38 palliative care patients showed significant symptom improvement, with pain scores dropping from a median of 8 to 2 on the Numeric Rating Scale (NRS) and 90% of patients responding; adverse events were minimal. This study indicates that rapid opioid titration is effective and well-tolerated in acute scenarios but emphasizes the need for careful monitoring for adverse events. Limitations include the small sample size and short observation period. Rapid intravenous opioid titration effectively alleviates acute pain and dyspnea in palliative care, with high patient satisfaction and low adverse events.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Nasrinfar K, Simonet V, Trippini A, Bosia T, Bruera E, Gamondi C

Citation: Nasrinfar K, Simonet V, Trippini A, et al. Rapid intravenous opioid titration for acute symptom crises in palliative care: a real-world retrospective study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026;34(10). doi:10.1007/s00520-026-11245-1

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.